HALF INDERAL LA 80MG PROLONGED-RELEASE CAPSULES
Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Summary of Product characteristics
(SPC)
21-03-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
PROPRANOLOL HYDROCHLORIDE
Available from:
PCO Manufacturing
Dosage:
80
Pharmaceutical form:
Prolonged Release Capsules
Authorization date:
2009-07-10
Summary of Product characteristics
License
Summary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT
Half-Inderal LA 80mg Prolonged-release Capsules
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each prolonged release capsule contains 80 mg of Propranolol Hydrochloride
For full list of excipients see 6.1
3 PHARMACEUTICAL FORM
Prolonged-release capsule.
Product imported from the UK:
Size no. 3 hard gelatin capsules having clear pink bodies and opaque lavender caps. They contain white to pale cream
coloured, odourless or almost odourless sphericals. The capsules are printed with the legend Half-Inderal LA in black
ink.
Product imported from Italy:
Hard gelatin capsules having clear pink bodies and opaque lavender caps. They contain white to pale cream coloured,
odourless or almost odourless sphericals. The capsules are printed with the legend “Inderal LA – 80” in black ink.
4 CLINICAL PARTICULARS
4.1 Therapeutic Indications
i.
Control of hypertension.
ii.
Management of Angina Pectoris.
iii. Prophylaxis of migraine.
iv.
Management of essential tremor
v.
Control of anxiety
vi.
Prophylaxis of upper gastrointestinal bleeding in patients with portal hypertension and oesophageal varices
vii. Adjunctive management of thyrotoxicosis
viii. Long-term prophylaxis after recovery from acute myocardial in
Read the complete document
